_tional Science and Vitaminology (Tokyo). 1 998 ;
_
Chlorea vulgaris on experimental atherosclerosis
—44(6):841-5 1.
-
and alimentary hypercholesterolerniaincholeste—
256. Novel antiretroviral sulfolipids extracted from
rol—fed ràbbits, Artery, 1987; 14(2):76-84.
spirulinae, method for obtaining same, com—
265. Takai Y et al :-Diabetes and Hypertension
positions containing same anduse thereof as
Reduction : E‘ecz‘ ofwater soluble and water
.
inhibitors of the HIV virus reverse transcriptase.
;
insolublefractions ofspirulina over serum lipids
Patent Agent: Dennison, Schultz, Dougherty &
and glucose resistance ofrats, J. Japan Soc. Nutr.
Macdonald —Alexanda, VA, US Patent Inven—
Food Science, 1991, 44 :273-277.
'
,
tors : Quoc Kiet Pham, Hubert Durand—Chastel
266. Yakamasi Y: Lost vision rapidly restored :
Application #: 20050245463 Class: 514024000
.
Continuous improvement in cases ofcafaracts,
-
(U SPT O) Related Patents: Drug, Bio—affecting
glaucoma, etc. In: Hills C Ed.: The Secrets of
And Body Treating Compositions, Designated
Spiruhna, University of the Trees Press, Boulder
—
Organic Active Ingredient Containing (doai), S—
Ca, 1980,
_
.
'
-
.
glycoside.
_
,
267. Merchant RE, CAAndre, DA Sica : NuÙitional
257. L intégration de la nutrition dans l’action
supplementaüon With Chlorella pyrenoidosa for
contre le WH/Sida, 59e Assemblée mondiale de
mild to moderate hypertension, J Med Food. 5,
la santé, n mai 2006, Genève.
3 2141—52, 2002. Merchan‘tRE & CAAndre : Are—
258. Ibid. Les besoins énergétiques « sont accrus
,
view ofrecent clinical trials ofthe nutritional supde 10% chez les adultes et les enfants infectés
plément Chlorellapyrenoiabsainthe treatment of
de manière asymptomaque >> ; chez les adultes
bromyalgia, hypertension, and ulcerative colitis,
3 2 3
malades, « ils sont accrus de 20% à 30%. Les
Altem Ther HealthMed 2001 ;7:79—80, 82—91.
.
adultes et les enfants infectés doivent bénécier
268. Huang JM, SM Bai, ZX Hu, CL Yang, DB
d’apports conformes aux quantitésj oumalières re—
Zhu, JP Shi: Effects of spirulina on serum lipids,
;
commandées, grâce à une alimentation diversiée,
erythrocyte membrane uidity and vascular endoà des aliments enrichis et âme supplémentation
thelial cells in tail—suspended rats, Space Med Med
selon les
-.
'
_
Eng (Beijing), 2003 Jun;16(3):184—6.
Z
259. Teas J, JR Hebert, JH Fitton, PV Zimba: Algae
269. Sukenik A, H Takahashi, S Mokady: Dietary
O
—apoor man’s HAART‘? Med Hypotheses, 2004;
lipids from marine unicellular algae enhance the
f-r
62(4)1507-10— —
,
,
__
amount of liver and blood omega—3 fatty acids in
8
260. Colloque lntemational 1RDCyanobactéa for
rats, Annals ofNutrition and Metabolism, 1994;
Health, science & development — Embiez Island
38(2):85-96- ,
_
,
E
3—6 mai 2004
,
270. Kushak R et al. : Favorable e"ects of blue—
É
261. Ibid.
_
-
green algae Aphanizomenon flos—aquae on rat
'Ô'“
261 +. Bachstetter AD, J emberg J, Schlunk A &
plasma lipids, Journal of the American NuIra—
LQ
coll.;”Spimhna promotes stem cell genesis and
ceutioal Association, January 2000; 2(3):59—65.
a
protects against LPS induced declines in neural
271. Khan M., et al. : Protective effect of Spinina
"O
stem cell proliferation”; PLoS One.2010 May
against doxombicin—induced cardiotoxicity, Phy—
3—5;5(5)1610496
'
.
'
'
tot/tempy Research, 2005 Dec; 19(12)21030-7.
5'
261 ++. Teas J, Irhimeh MR;”Dietary algae and
272. Selon le Programme national de réduction des
:
HIV/AIDS : proof of concept clinical dataî’; J
risques cardiovasculaires 2002—2005, le bilan est
(D
Appl Phycol.2012 Jun;24(3)z575-58—2
_
»
très lourd; 120 000 infarctus du myocarde et 130
“"
262. Levy Y et al. : Dietary supplémentation of a
000 accidents vasculaires cérébraux (AVC) avec
natural isomer mixture of beta—caroténe inhibits
.,
180 000 décès et de très nombreuses séquelles
oxidation ofLDL derived om patients With Dia—
irréversibles.
-
275. Rosenson RS: Lowering LDL cholesterol re—
lism, March 2000; 44(2):54—60.
duces risk ofischaemic heart disease events. Evi—
262 +_. Pétrus M.
,
Assih L., Horen B. & coll;“First
dence—basedHealf/æcæe 2004; 8:48—9. Law MR,
case of allergy to spiruline ina 13—year-old
—
Wald NJ, Wu T, Hackshaw A, Bailey A.: Sys—
child”;Doi : 10. 1016/jreval.2010.06.01 1
tematic underestimaüon of association between
262 ++. Juarez—Oropeza MA, Mascher D,Torres—
serum cholesterol cbncentraon and ischaemic
Duran PV & coll.; “Effects of dietary Spirulina
heart disease in observational studies: data from
_
on vascular reactivity” ; J Med Food 2009 Fev;
the BUPA study. BMJ 1994; 308; 363—6.
12(1):15-20
274. Law MR, Wald NJ, Morris JK, Jordan RE:
265. Cohen Z, HNonnan, Y Heimer: Microalgae
Value of low dose combination treatment with
as a source of omega three fatty acids, Plants in
blood pressure lowering drugs: analysis of 354
Human Nutrition, 1995; 7711—3 1.
,
.
randomised trials. BMJ 2003, 326 :1427—3 1
.
Cir—
264. Sano T & YTankaka : E"ect ofdried, powdered
»
culation 2004; 110:227—239.
-
°
_
Chlorea vulgaris on experimental atherosclerosis
—44(6):841-5 1.
-
and alimentary hypercholesterolerniaincholeste—
256. Novel antiretroviral sulfolipids extracted from
rol—fed ràbbits, Artery, 1987; 14(2):76-84.
spirulinae, method for obtaining same, com—
265. Takai Y et al :-Diabetes and Hypertension
positions containing same anduse thereof as
Reduction : E‘ecz‘ ofwater soluble and water
.
inhibitors of the HIV virus reverse transcriptase.
;
insolublefractions ofspirulina over serum lipids
Patent Agent: Dennison, Schultz, Dougherty &
and glucose resistance ofrats, J. Japan Soc. Nutr.
Macdonald —Alexanda, VA, US Patent Inven—
Food Science, 1991, 44 :273-277.
'
,
tors : Quoc Kiet Pham, Hubert Durand—Chastel
266. Yakamasi Y: Lost vision rapidly restored :
Application #: 20050245463 Class: 514024000
.
Continuous improvement in cases ofcafaracts,
-
(U SPT O) Related Patents: Drug, Bio—affecting
glaucoma, etc. In: Hills C Ed.: The Secrets of
And Body Treating Compositions, Designated
Spiruhna, University of the Trees Press, Boulder
—
Organic Active Ingredient Containing (doai), S—
Ca, 1980,
_
.
'
-
.
glycoside.
_
,
267. Merchant RE, CAAndre, DA Sica : NuÙitional
257. L intégration de la nutrition dans l’action
supplementaüon With Chlorella pyrenoidosa for
contre le WH/Sida, 59e Assemblée mondiale de
mild to moderate hypertension, J Med Food. 5,
la santé, n mai 2006, Genève.
3 2141—52, 2002. Merchan‘tRE & CAAndre : Are—
258. Ibid. Les besoins énergétiques « sont accrus
,
view ofrecent clinical trials ofthe nutritional supde 10% chez les adultes et les enfants infectés
plément Chlorellapyrenoiabsainthe treatment of
de manière asymptomaque >> ; chez les adultes
bromyalgia, hypertension, and ulcerative colitis,
3 2 3
malades, « ils sont accrus de 20% à 30%. Les
Altem Ther HealthMed 2001 ;7:79—80, 82—91.
.
adultes et les enfants infectés doivent bénécier
268. Huang JM, SM Bai, ZX Hu, CL Yang, DB
d’apports conformes aux quantitésj oumalières re—
Zhu, JP Shi: Effects of spirulina on serum lipids,
;
commandées, grâce à une alimentation diversiée,
erythrocyte membrane uidity and vascular endoà des aliments enrichis et âme supplémentation
thelial cells in tail—suspended rats, Space Med Med
selon les
-.
'
_
Eng (Beijing), 2003 Jun;16(3):184—6.
Z
259. Teas J, JR Hebert, JH Fitton, PV Zimba: Algae
269. Sukenik A, H Takahashi, S Mokady: Dietary
O
—apoor man’s HAART‘? Med Hypotheses, 2004;
lipids from marine unicellular algae enhance the
f-r
62(4)1507-10— —
,
,
__
amount of liver and blood omega—3 fatty acids in
8
260. Colloque lntemational 1RDCyanobactéa for
rats, Annals ofNutrition and Metabolism, 1994;
Health, science & development — Embiez Island
38(2):85-96- ,
_
,
E
3—6 mai 2004
,
270. Kushak R et al. : Favorable e"ects of blue—
É
261. Ibid.
_
-
green algae Aphanizomenon flos—aquae on rat
'Ô'“
261 +. Bachstetter AD, J emberg J, Schlunk A &
plasma lipids, Journal of the American NuIra—
LQ
coll.;”Spimhna promotes stem cell genesis and
ceutioal Association, January 2000; 2(3):59—65.
a
protects against LPS induced declines in neural
271. Khan M., et al. : Protective effect of Spinina
"O
stem cell proliferation”; PLoS One.2010 May
against doxombicin—induced cardiotoxicity, Phy—
3—5;5(5)1610496
'
.
'
'
tot/tempy Research, 2005 Dec; 19(12)21030-7.
5'
261 ++. Teas J, Irhimeh MR;”Dietary algae and
272. Selon le Programme national de réduction des
:
HIV/AIDS : proof of concept clinical dataî’; J
risques cardiovasculaires 2002—2005, le bilan est
(D
Appl Phycol.2012 Jun;24(3)z575-58—2
_
»
très lourd; 120 000 infarctus du myocarde et 130
“"
262. Levy Y et al. : Dietary supplémentation of a
000 accidents vasculaires cérébraux (AVC) avec
natural isomer mixture of beta—caroténe inhibits
.,
180 000 décès et de très nombreuses séquelles
oxidation ofLDL derived om patients With Dia—
irréversibles.
-
275. Rosenson RS: Lowering LDL cholesterol re—
lism, March 2000; 44(2):54—60.
duces risk ofischaemic heart disease events. Evi—
262 +_. Pétrus M.
,
Assih L., Horen B. & coll;“First
dence—basedHealf/æcæe 2004; 8:48—9. Law MR,
case of allergy to spiruline ina 13—year-old
—
Wald NJ, Wu T, Hackshaw A, Bailey A.: Sys—
child”;Doi : 10. 1016/jreval.2010.06.01 1
tematic underestimaüon of association between
262 ++. Juarez—Oropeza MA, Mascher D,Torres—
serum cholesterol cbncentraon and ischaemic
Duran PV & coll.; “Effects of dietary Spirulina
heart disease in observational studies: data from
_
on vascular reactivity” ; J Med Food 2009 Fev;
the BUPA study. BMJ 1994; 308; 363—6.
12(1):15-20
274. Law MR, Wald NJ, Morris JK, Jordan RE:
265. Cohen Z, HNonnan, Y Heimer: Microalgae
Value of low dose combination treatment with
as a source of omega three fatty acids, Plants in
blood pressure lowering drugs: analysis of 354
Human Nutrition, 1995; 7711—3 1.
,
.
randomised trials. BMJ 2003, 326 :1427—3 1
.
Cir—
264. Sano T & YTankaka : E"ect ofdried, powdered
»
culation 2004; 110:227—239.
-
°